ValiRx (VAL) Competitors GBX 1.67 -0.01 (-0.30%) (As of 12:37 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines VAL vs. EOG, HNR, NOG, SUN, WRES, WEB, EQT, CRC, NBL, and FTOShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include Europa Oil & Gas (EOG), Highlands Natural Resources (HNR), Nostrum Oil & Gas (NOG), Surgical Innovations Group (SUN), W Resources (WRES), Webis (WEB), EQTEC (EQT), Circle Property (CRC), 18564 (NBL.L) (NBL), and 2059984 (FTO.L) (FTO). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. Europa Oil & Gas Highlands Natural Resources Nostrum Oil & Gas Surgical Innovations Group W Resources Webis EQTEC Circle Property 18564 (NBL.L) 2059984 (FTO.L) Europa Oil & Gas (LON:EOG) and ValiRx (LON:VAL) are both small-cap energy companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings. Does the media refer more to EOG or VAL? In the previous week, ValiRx had 3 more articles in the media than Europa Oil & Gas. MarketBeat recorded 3 mentions for ValiRx and 0 mentions for Europa Oil & Gas. Europa Oil & Gas' average media sentiment score of 0.00 beat ValiRx's score of -0.37 indicating that Europa Oil & Gas is being referred to more favorably in the media. Company Overall Sentiment Europa Oil & Gas Neutral ValiRx Neutral Do institutionals & insiders hold more shares of EOG or VAL? 15.0% of Europa Oil & Gas shares are owned by institutional investors. 13.5% of Europa Oil & Gas shares are owned by company insiders. Comparatively, 18.3% of ValiRx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is EOG or VAL more profitable? ValiRx has a net margin of 0.00% compared to Europa Oil & Gas' net margin of -13.45%. Europa Oil & Gas' return on equity of -6.05% beat ValiRx's return on equity.Company Net Margins Return on Equity Return on Assets Europa Oil & Gas-13.45% -6.05% 3.90% ValiRx N/A -55.38%-35.98% Does the MarketBeat Community favor EOG or VAL? Europa Oil & Gas received 55 more outperform votes than ValiRx when rated by MarketBeat users. However, 51.55% of users gave ValiRx an outperform vote while only 50.00% of users gave Europa Oil & Gas an outperform vote. CompanyUnderperformOutperformEuropa Oil & GasOutperform Votes20550.00% Underperform Votes20550.00% ValiRxOutperform Votes15051.55% Underperform Votes14148.45% Which has more risk & volatility, EOG or VAL? Europa Oil & Gas has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Comparatively, ValiRx has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Which has preferable earnings & valuation, EOG or VAL? Europa Oil & Gas has higher revenue and earnings than ValiRx. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEuropa Oil & Gas£4.38M1.62£1.36MN/AN/AValiRxN/AN/A-£1.97M-£0.02-83.50 SummaryEuropa Oil & Gas beats ValiRx on 9 of the 13 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£2.22M£164.86M£5.07B£1.39BDividend Yield0.63%3.25%4.99%11.73%P/E Ratio-83.75329.4787.861,549.36Price / SalesN/A14,996.691,228.82209,059.57Price / Cash62.5011.6739.5132.93Price / Book0.567.126.942.80Net Income-£1.97M-£18.52M£119.12M£152.70M7 Day PerformanceN/A-0.22%-1.84%-0.51%1 Month Performance-22.99%8.10%-3.65%7.11%1 Year Performance-83.63%26.08%31.64%91.82% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 1.67-0.3%N/A-83.5%£2.21MN/A-83.505,450Gap DownEOGEuropa Oil & GasN/AGBX 0.74-1.2%N/A-35.6%£7.11M£4.38M23.502,850Gap UpHNRHighlands Natural ResourcesN/AGBX 4.70-3.1%N/A+0.0%£6.95M£1.02M-0.9616Gap DownHigh Trading VolumeNOGNostrum Oil & Gas1.839 of 5 starsGBX 4.07+0.6%GBX 14+244.0%-60.8%£6.88M£132.09M-0.8730Gap DownSUNSurgical Innovations GroupN/AGBX 0.50-9.1%N/A-43.8%£4.66M£12.54M-21.1180WRESW ResourcesN/AGBX 2.65flatN/A+0.0%£3.89M£3.47M-0.4366Gap DownWEBWebisN/AGBX 0.48+20.0%N/A-68.6%£1.89M£49.70M14.1350Negative NewsGap UpEQTEQTECN/AGBX 0.69+2.1%N/A+1,650.0%£1.78M£3.85M-3.97740Gap DownCRCCircle PropertyN/AGBX 3.50-12.5%N/A+0.0%£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000 Related Companies and Tools Related Companies Europa Oil & Gas Alternatives Highlands Natural Resources Alternatives Nostrum Oil & Gas Alternatives Surgical Innovations Group Alternatives W Resources Alternatives Webis Alternatives EQTEC Alternatives Circle Property Alternatives 18564 (NBL.L) Alternatives 2059984 (FTO.L) Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:VAL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
